Literature DB >> 7869467

Illicit use of methadone among i.v. drug users in Montreal.

P Lauzon1, J Vincelette, J Bruneau, F Lamothe, N Lachance, M Brabant, J Soto.   

Abstract

Few studies have been done on the prevalence of illicit methadone use. Five hundred fifty-nine IV drug users recruited in various ways in Montreal were interviewed concerning their drug use as part of a longitudinal study on HIV infection. Of this number, 133 had heroin as their drug of preference and 426 cocaine. Among the cocaine group, 202 also used heroin. The lifetime prevalence of any illicit methadone use was 59.4% in the heroin group, 26.7% in the cocaine/heroin group, and 3.6% in the cocaine-only group. The 6-month (preceding the interview) prevalence of any illicit use was 42.1%, 6.9%, and 1.3%, respectively, and the prevalence of at least weekly illicit use during that period was 6.3%, 2.0%, and 0%, respectively. The prevalence of illicit methadone use is significant in the population studied. Whether this level of use will be affected by more stringent control on methadone prescription and dispensation remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7869467     DOI: 10.1016/0740-5472(94)90099-x

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  14 in total

1.  The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.

Authors:  Toni-Kim Clarke; Amy R D Weiss; Thomas N Ferarro; Kyle M Kampman; Charles A Dackis; Helen M Pettinati; Charles P O'brien; David W Oslin; Falk W Lohoff; Wade H Berrettini
Journal:  Ann Hum Genet       Date:  2013-11-25       Impact factor: 1.670

2.  Characteristics Associated with Nonmedical Methadone Use among People Who Inject Drugs in California.

Authors:  Johnathan K Zhao; Alex H Kral; Lynn D Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2019-10-14       Impact factor: 2.164

3.  Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales.

Authors:  J Strang; J Sheridan; N Barber
Journal:  BMJ       Date:  1996-08-03

4.  Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Authors:  Toni-Kim Clarke; Richard C Crist; Kyle M Kampman; Charles A Dackis; Helen M Pettinati; Charles P O'Brien; David W Oslin; Thomas N Ferraro; Falk W Lohoff; Wade H Berrettini
Journal:  Neurosci Lett       Date:  2013-02-20       Impact factor: 3.046

5.  Asymmetric generalization and interaction profiles in rhesus monkeys discriminating intravenous cocaine or intravenous heroin from vehicle.

Authors:  Donna M Platt; James K Rowlett; Roger D Spealman
Journal:  J Pharmacol Exp Ther       Date:  2009-12-04       Impact factor: 4.030

6.  Factors associated with illicit methadone injecting in a Canadian setting.

Authors:  Devin Tucker; M-J Milloy; Kanna Hayashi; Paul Nguyen; Thomas Kerr; Evan Wood
Journal:  Am J Addict       Date:  2015-08-18

7.  Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study.

Authors:  Li-Tzy Wu; Dan G Blazer; Maxine L Stitzer; Ashwin A Patkar; Jack D Blaine
Journal:  Am J Addict       Date:  2008 Jul-Aug

8.  Heroin and cocaine co-use in a group of injection drug users in Montréal.

Authors:  Francesco Leri; Jane Stewart; Annie Tremblay; Julie Bruneau
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

9.  Kinetic characterization of cholinesterases and a therapeutically valuable cocaine hydrolase for their catalytic activities against heroin and its metabolite 6-monoacetylmorphine.

Authors:  Kyungbo Kim; Jianzhuang Yao; Zhenyu Jin; Fang Zheng; Chang-Guo Zhan
Journal:  Chem Biol Interact       Date:  2018-08-04       Impact factor: 5.192

10.  Prelimbic cortex is a common brain area activated during cue-induced reinstatement of cocaine and heroin seeking in a polydrug self-administration rat model.

Authors:  Francisco J Rubio; Richard Quintana-Feliciano; Brandon L Warren; Xuan Li; Kailyn F R Witonsky; Frank Soto Del Valle; Pooja V Selvam; Daniele Caprioli; Marco Venniro; Jennifer M Bossert; Yavin Shaham; Bruce T Hope
Journal:  Eur J Neurosci       Date:  2018-11-09       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.